Laboratorio Reig Jofre, S.A. (LON:0RB1)

London · Delayed Price · Currency is GBP · Price in EUR

2.740

+0.050 (1.86%)

At close: Aug 4, 2026

-8.21% (1Y)

Market Cap	185.67M -11.1%
Revenue (ttm)	290.81M +0.3%
Net Income	5.97M +8.7%
EPS	n/a
Shares Out	n/a
PE Ratio	31.09
Forward PE	13.02
Dividend	0.02 (0.72%)
Ex-Dividend Date	May 21, 2026

Volume	204
Open	2.730
Previous Close	2.690
Day's Range	2.730 - 2.740
52-Week Range	2.340 - 3.290
Beta	0.95
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 31, 2026

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmaceuticals, food, and other products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; and food supplements under the For... [Read more]

Industry Medicinal Chemicals and Botanical Products

Founded 1929

Employees 1,512

Stock Exchange London Stock Exchange

Ticker Symbol 0RB1

Financial Performance

In 2025, Laboratorio Reig Jofre's revenue was 336.68 million, a decrease of -1.37% compared to the previous year's 341.37 million. Earnings were 5.02 million, a decrease of -51.64%.

Financial numbers in EUR Financial Statements